• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌中组织蛋白酶D检测:与病理特征及雌激素、孕激素和表皮生长因子受体的相关性

Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.

作者信息

Scambia G, Benedetti P, Ferrandina G, Battaglia F, Baiocchi G, Mancuso S

机构信息

Department of Gynecology, Catholic University, Rome, Italy.

出版信息

Br J Cancer. 1991 Jul;64(1):182-4. doi: 10.1038/bjc.1991.266.

DOI:10.1038/bjc.1991.266
PMID:1854619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1977323/
Abstract

Using an immunoradiometric assay, Cathepsin-D (Cath-D) concentrations were measured in the cytosol of 68 normal and neoplastic human ovarian tissues. Cath-D levels were higher in malignant tumours than in normal tissue samples (P less than 0.01) and benign tumours (P less than 0.01). In six out of seven cases, metastatic deposits showed Cath-D concentrations higher than the respective primary tumours. Using 12 of 17 pmols.mg-1 protein as cut-off levels, the Cath-D status (high or low) was not related to any pathological parameter. Moreover, no correlation was found between Cath-D levels and receptors for oestrogen, progesterone and epidermal growth factor. Our results indicate that ovarian tumours produce Cath-D. Further studies are needed to evaluate whether this protein could represent a prognostic factor for this neoplasia.

摘要

采用免疫放射分析方法,测定了68例正常和肿瘤性人卵巢组织胞浆中组织蛋白酶D(Cath-D)的浓度。恶性肿瘤中的Cath-D水平高于正常组织样本(P<0.01)和良性肿瘤(P<0.01)。在7例中的6例中,转移灶的Cath-D浓度高于各自的原发肿瘤。以17 pmols.mg-1蛋白质中的12个作为临界水平,Cath-D状态(高或低)与任何病理参数均无关联。此外,未发现Cath-D水平与雌激素、孕激素和表皮生长因子受体之间存在相关性。我们的结果表明卵巢肿瘤会产生Cath-D。需要进一步研究以评估这种蛋白质是否可能代表这种肿瘤的一个预后因素。

相似文献

1
Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.卵巢癌中组织蛋白酶D检测:与病理特征及雌激素、孕激素和表皮生长因子受体的相关性
Br J Cancer. 1991 Jul;64(1):182-4. doi: 10.1038/bjc.1991.266.
2
Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
Int J Cancer. 1994 May 15;57(4):468-72. doi: 10.1002/ijc.2910570405.
3
Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor status.原发性喉鳞状细胞癌中的组织蛋白酶D:与临床病理参数及受体状态的相关性
Cancer Lett. 1992 Dec 24;67(2-3):133-8. doi: 10.1016/0304-3835(92)90136-j.
4
Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx.
Eur J Cancer B Oral Oncol. 1994 Jan;30B(1):51-5. doi: 10.1016/0964-1955(94)90051-5.
5
Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
Int J Cancer. 1992 Sep 9;52(2):218-24. doi: 10.1002/ijc.2910520211.
6
Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor.
Am J Obstet Gynecol. 1993 Jan;168(1 Pt 1):71-8. doi: 10.1016/s0002-9378(12)90888-1.
7
Expression of cathepsin-D, CA125 and epidermal growth factor receptor in imprint smears of ovarian carcinoma.
Gynecol Obstet Invest. 1997;43(2):125-30. doi: 10.1159/000291837.
8
Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
Eur J Cancer. 1993;29A(3):426-8. doi: 10.1016/0959-8049(93)90401-z.
9
Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.组织学分级低的淋巴结阴性乳腺癌患者亚组中组织蛋白酶D和c-erbB-2癌蛋白的预后影响
Int J Oncol. 2001 Apr;18(4):793-800.
10
Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.卵巢癌中组织蛋白酶D免疫反应性:与预后因素的相关性
Pathol Oncol Res. 1998;4(2):103-7. doi: 10.1007/BF02904702.

引用本文的文献

1
Spotlight on Proteases: Roles in Ovarian Health and Disease.蛋白酶聚焦:在卵巢健康与疾病中的作用
Cells. 2025 Jun 18;14(12):921. doi: 10.3390/cells14120921.
2
Ultrasensitive, multiplexed chemoproteomic profiling with soluble activity-dependent proximity ligation.基于可溶性活性依赖型邻近连接的超高灵敏、多重化学蛋白质组学分析。
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21493-21500. doi: 10.1073/pnas.1912934116. Epub 2019 Oct 7.
3
Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome.
Br J Cancer. 1998 Dec;78(12):1645-52. doi: 10.1038/bjc.1998.737.
4
Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.卵巢癌中组织蛋白酶D免疫反应性:与预后因素的相关性
Pathol Oncol Res. 1998;4(2):103-7. doi: 10.1007/BF02904702.
5
Hormone receptors and cathepsin D levels in human breast epithelial cells transformed by chemical carcinogens and c-Ha-ras transfection.化学致癌物和c-Ha-ras转染转化的人乳腺上皮细胞中的激素受体和组织蛋白酶D水平
Breast Cancer Res Treat. 1994 Feb;29(2):169-77. doi: 10.1007/BF00665678.
6
Extracellular matrix components and proteolytic enzymes in uterine cervical carcinoma.子宫颈癌中的细胞外基质成分和蛋白水解酶
Mol Cell Biochem. 1995 Mar 9;144(1):35-43. doi: 10.1007/BF00926738.
7
Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells.原发性乳腺癌中的组织蛋白酶D:不良预后与基质细胞中组织蛋白酶D的表达相关。
Breast Cancer Res Treat. 1995;33(2):137-45. doi: 10.1007/BF00682721.

本文引用的文献

1
Progesterone and estrogen control of rates of synthesis of uterine cathepsin D.
J Biol Chem. 1980 Aug 10;255(15):7474-9.
2
Biosynthesis and transport of lysosomal enzymes in human monocytes and macrophages. Effects of ammonium chloride, zymosan and tunicamycin.人单核细胞和巨噬细胞中溶酶体酶的生物合成与转运。氯化铵、酵母聚糖和衣霉素的作用。
Biochem J. 1983 Sep 15;214(3):671-8. doi: 10.1042/bj2140671.
3
Human transforming growth factor-alpha: precursor structure and expression in E. coli.人转化生长因子-α:前体结构及在大肠杆菌中的表达
Cell. 1984 Aug;38(1):287-97. doi: 10.1016/0092-8674(84)90550-6.
4
Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.雌激素调节的52K蛋白对MCF 7乳腺癌细胞的自分泌生长刺激作用。
Endocrinology. 1986 Apr;118(4):1537-45. doi: 10.1210/endo-118-4-1537.
5
Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions.在酸性条件下,鸡胚成纤维细胞中的高分子量潜伏性β-转化生长因子转化为低分子量活性β-转化生长因子。
Biochem Biophys Res Commun. 1985 Dec 31;133(3):1026-34. doi: 10.1016/0006-291x(85)91239-2.
6
Distribution of the Mr 52,000 estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry.
Cancer Res. 1986 Jul;46(7):3734-8.
7
The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease.
Biochem Biophys Res Commun. 1986 Jul 16;138(1):102-9. doi: 10.1016/0006-291x(86)90252-4.
8
In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.乳腺癌细胞分泌的分子量为52,000的组织蛋白酶D对细胞外基质的体外降解作用
Cancer Res. 1988 Jul 1;48(13):3688-92.
9
Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas.人附属器肿瘤中表皮生长因子受体的出现及其在晚期卵巢癌中的预后价值。
Gynecol Oncol. 1988 Feb;29(2):147-57. doi: 10.1016/0090-8258(88)90209-0.
10
Immunohistochemical distribution of the 52-kDa protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness.52-kDa蛋白在乳腺肿瘤中的免疫组化分布:一种与细胞增殖而非激素反应性相关的标志物。
J Steroid Biochem. 1987;27(1-3):439-45. doi: 10.1016/0022-4731(87)90338-4.